Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Cazeau Al"'
Publikováno v:
Journal of Cancer Research & Therapy, Vol 1, Iss 1, Pp 46-53 (2013)
Purpose: to evaluate the diagnostic accuracy of (18) F-FDG positron emission tomography/ computerized tomography (PET/CT) for the detection of peritoneal carcinomatosis (PC) of colorectal cancer (CRC). Methods: one hundred and forty six eligible pati
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Letang A; From the Departments of Nuclear Medicine., Crombé A, Rousseau C; ICO René Gauducheau, F-44800 Saint-Herblain, Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, F-44000 Nantes., Sargos P; Department of Radiotherapy, Institut Bergonié, Bordeaux., Merlin C; Department of Nuclear Medicine, Centre Jean Perrin Cancer Center, Clermont-Ferrand., Cantarel C; Clinical and Epidemiological Research Unit, INSERM CIC1401, Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France., Cazeau AL; From the Departments of Nuclear Medicine.
Publikováno v:
Clinical nuclear medicine [Clin Nucl Med] 2022 Aug 01; Vol. 47 (8), pp. e529-e539. Date of Electronic Publication: 2022 May 11.
Autor:
Bertolaso P; Department of Medical Oncology, University Hospital, Bordeaux, France. Electronic address: pauline.bertolaso@chu-bordeaux.fr., Brouste V; Clinical and Epidemiology Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Cazeau AL; Nuclear Medicine Department, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., de Clermont-Gallerande H; Nuclear Medicine Department, University Hospital of Bordeaux, Bordeaux, France; University of Bordeaux, Bordeaux, France., Bladou F; University of Bordeaux, Bordeaux, France; Department of Urology, University Hospital, Bordeaux, France., Cabart M; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Lefort F; Department of Medical Oncology, University Hospital, Bordeaux, France., Gross-Goupil M; Department of Medical Oncology, University Hospital, Bordeaux, France.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Jun; Vol. 20 (3), pp. 297-297.e6. Date of Electronic Publication: 2022 Jan 14.
Autor:
Béchade D; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France; Univ. Bordeaux, 146 rue Léo Saignat, 33000 Bordeaux, France. Electronic address: dominique.bechade94@orange.fr., Bellera C; Inserm CIC1401, Clinical and Epidemiological Research Unit, Institut Bergonié, 229 Cours de l'Argonne, 33076 Bordeaux, France; Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000 Bordeaux, France., Gauquelin L; Inserm CIC1401, Clinical and Epidemiological Research Unit, Institut Bergonié, 229 Cours de l'Argonne, 33076 Bordeaux, France., Soubeyran I; Department of Pathology, Institut Bergonié, 33076 Bordeaux, France., McKelvie-Sebileau P; University of Auckland, Auckland, New Zealand., Debled M; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France., Chomy F; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France., Roubaud G; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France., Fonck M; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France., Pernot S; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, F-33000 Bordeaux, France; Univ. Bordeaux, 146 rue Léo Saignat, 33000 Bordeaux, France., Roch A; Department of Nuclear Medicine, Institut Bergonié, 33076 Bordeaux, France., Cazeau AL; Department of Nuclear Medicine, Institut Bergonié, 33076 Bordeaux, France.
Publikováno v:
Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2022 May; Vol. 46 (5), pp. 101912. Date of Electronic Publication: 2022 Mar 25.
Autor:
Crombé A; Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France; Bordeaux University, 33000 Bordeaux, France; Modelisation in Oncology (MOnc) Team, INRIA Bordeaux-Sud-Ouest, CNRS UMR 5251, 33405, Talence, France. Electronic address: a.crombe@bordeaux.unicancer.fr., Gauquelin L; Department of Biostatistics, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Nougaret S; Department of Radiology, Montpellier Cancer Institute, University of Montpellier, 34090 Montpellier, France., Chicart M; Department of nuclear medicine, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Pulido M; Department of Biostatistics, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Floquet A; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Guyon F; Department of Oncological Surgery, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Croce S; Department of Pathology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Kind M; Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France., Cazeau AL; Department of nuclear medicine, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France.
Publikováno v:
Diagnostic and interventional imaging [Diagn Interv Imaging] 2021 Oct; Vol. 102 (10), pp. 629-639. Date of Electronic Publication: 2021 Jun 07.
Autor:
Giraud N; Radiation Oncology Department, Institut Bergonié, Bordeaux, France., Buy X; Oncologic Imaging Department, Institut Bergonié, Bordeaux, France., Vuong NS; Urology Department, Clinique Saint Augustin, Bordeaux, France., Gaston R; Urology Department, Clinique Saint Augustin, Bordeaux, France., Cazeau AL; Nuclear Medicine Department, Institut Bergonié, Bordeaux, France., Catena V; Oncologic Imaging Department, Institut Bergonié, Bordeaux, France., Palussiere J; Oncologic Imaging Department, Institut Bergonié, Bordeaux, France., Roubaud G; Medical Oncology Department, Institut Bergonié, Bordeaux, France., Sargos P; Radiation Oncology Department, Institut Bergonié, Bordeaux, France.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Jul 26; Vol. 11, pp. 709779. Date of Electronic Publication: 2021 Jul 26 (Print Publication: 2021).
Autor:
Karahissarlian V; Department of Radiation Oncology, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France., Sargos P; Department of Radiation Oncology, Jewish General Hospital, 3755, Côte-Sainte-Catherine road, Montreal, Quebec H3T 1E2, Canada. Electronic address: p.sargos@bordeaux.unicancer.fr., Blais E; Department of Radiation Oncology, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France., Cazeau AL; Department of Nuclear Medicine, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France., Fontes F; Interventional Radiology, nouvelle clinique Bel-Air, 138, avenue de la République, 33000 Bordeaux, France., Petitpierre F; Interventional Radiology, service d'imagerie diagnostique et thérapeutique de l'adulte, hôpital Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France., Rigou G; IRMBA, centre de radiologie et d'imagerie médicale, hôpital d'Arcachon, avenue Jean-Hameau, 33164 La Teste-de-Buch, France., De Vaugelade C; Department of Nuclear Medicine, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France., Mariey A; Department of Nuclear Medicine, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France., Hindié E; Department of Nuclear Medicine, hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33600 Pessac, France., Thomas L; Department of Radiation Oncology, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France.
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2020 Jul; Vol. 24 (4), pp. 323-331. Date of Electronic Publication: 2020 Jun 10.